Avadel Pharmaceuticals Announces Publication of Real-World Data Highlighting the Risk of Accidental Dosing Errors with Immediate-Release Twice-Nightly Oxybates
SNN,
- Adverse events were reported in patients who took the second, middle-of-the-night dose of immediate-release oxybate less than…